Navigation Links
Plum Alley Closes $1.5M in Syndicate with Women and Men Investing in CRISPR-based Diagnostics Company
Date:8/9/2018

Plum Alley Investments, an innovative platform providing new investors, especially women, access to invest in disruptive technology and healthcare companies, has invested in a sought-after $23 million Series A round for Mammoth Biosciences as it comes out of stealth mode.

CRISPR Technology and Mammoth Biosciences
The biotech company is bringing to market the latest CRISPR innovations in partnership with legendary Dr. Jennifer Doudna and members of the Innovative Genomics Institute (IGI) team. Plum Alley’s relationship with Mammoth grew out of their recent collaboration with IGI and Dr. Doudna’s team on InsideView™, a private session for Plum Alley’s elite members. Plum Alley’s recent InsideView™ provided access to IGI and an in-depth experience to learn about the CRISPR technology and applications across biomedicine, healthcare, agriculture, biofuel, and other industries.

While the discovery of CRISPR has led to an expanding field of gene editing and modification companies focused on therapeutics, Mammoth Biosciences is using the technology’s scientific and technological breakthrough for diagnostics, and has invented new ways to test and detect using CRISPR’s search functionality. As explained by Mammoth Co-founder and CTO Ashley Tehranchi, “We leverage CRISPR as a search engine, using a guide RNA to direct a CRISPR protein to search for any specific DNA or RNA sequence. That process provides a world of utility across fields like forensic, genotyping, oncology, infectious disease, agriculture and even oil and gas industries.”

Mammoth Series A Investors
The current round was led by Mayfield with participation from NFX, 8VC, DHVC, Plum Alley, alongside high profile individual investors including Apple’s Tim Cook. Plum Alley’s syndicate invested nearly $1.5 million, 75% of the amount coming from women investors who would not have had the access or opportunity otherwise to invest. The Plum Alley syndicate is comprised of both women and men who bring value beyond their money, by nature of their positions as Directors of public company boards, as corporate executives, or non-profit board members.

Trevor Martin, Co-founder and CEO said, “Plum Alley’s participation in our raise was important to us as we selected our investors. Their members bring tremendous strategic value to Mammoth as we consider strong and additive partners to drive our commercial access. With a founding team of highly credentialed women and men, we know deep expertise and talent resides in a diverse and inclusive pool, and we appreciate investors that reflect those values.”

Plum Alley’s funding and strategic support will help Mammoth develop the platform that also allows partners access and to search for their own biomarkers. Partnerships are central to Mammoth’s business, and the company aims to make its CRISPR-powered search engine the platform of choice for disease detection. Mammoth aims to democratize disease detection with an easy and affordable test that allows fast, simultaneous detection of multiple conditions, in real time - which has the potential to significantly impact healthcare accessibility both domestically and in the developing world. Beyond healthcare, the platform has applications across industries, with the team keeping a keen eye on partnerships in the pharmaceutical and agricultural industries.

Mammoth is led by two Stanford PhDs, Trevor Martin (CEO) and Ashley Tehranchi (CTO), and two Berkeley PhDs, Lucas Harrington (Chief Discovery Officer) and Janice Chen (Chief Research Officer). Dr. Jennifer Doudna is also a Mammoth Co-founder and chair of the company’s advisory board.

Read the full story at https://www.prweb.com/releases/plum_alley_closes_1_5m_in_syndicate_with_women_and_men_investing_in_crispr_based_diagnostics_company/prweb15680429.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Study shows reforestation in Lower Mississippi Valley reduces sediment
2. A new toad from the warm valleys of Peruvian Andes
3. Alps to Appalachia; submarine channels to Tibetan plateau; Death Valley to arctic Canada
4. Alley elected Foreign Member of Royal Society
5. Exceptionally well preserved insect fossils from the Rhône Valley
6. Exceptionally well preserved insect fossils from the Rhône Valley
7. Kent State researchers to develop mobile app for Cuyahoga Valley National Park
8. The valley of death facing physics start-ups
9. Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution
10. The closest relatives of papaya are 4 species from Mexico and Guatemala
11. Pressure BioSciences Closes Additional $745,000 of $5 Million PIPE; Funding Received to Date Exceeds $4,000,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2019)... ... February 01, 2019 , ... uBiome, the leader in microbial ... which establishes requirements for medical laboratories to demonstrate competence to deliver timely, accurate, ... well as College of American Pathologists (CAP)-accredited, a designation given to the top ...
(Date:1/25/2019)... ... January 24, 2019 , ... uBiome, the leader in ... Microbiology at the Jackson Laboratory (JAX), to its Scientific Advisory Board. Joining the ... bring to uBiome expertise in skin microbial interactions and probiotic treatments for skin ...
(Date:1/25/2019)... ... January 24, 2019 , ... Review methodology could negatively impact ... continue to grapple with prescription drug costs, a new Pioneer Institute study ... address before deciding whether to contract with the Institute for Clinical and Economic ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... YANTAI, China and SAN DIEGO (PRWEB) , ... ... ... a leading and fully integrated Contract Development and Manufacturing Organization (CDMO) serving the ... has closed its series A funding of $59.1 million backed by multiple global ...
(Date:1/30/2019)... ... January 30, 2019 , ... The Society for ... agencies to discuss best practices for laboratory automation and screening. This year the ... this year’s conference, Visikol will be at booth #345 and throughout the conference ...
(Date:1/24/2019)... , ... January 22, 2019 , ... Dr. Douglas Stramel ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. ... Regenerative Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is ...
(Date:1/20/2019)... YORK (PRWEB) , ... January 17, 2019 , ... ... clinical testing was, until recently, the exclusive purview of physicians. That's changing as ... The global direct to consumer (DTC) laboratory testing market totaled $208 million in ...
Breaking Biology Technology: